Elderly immune response to a TI-2 antigen: Heavy and light chain use and bactericidal activity to Neisseria meningitidis serogroup C polysaccharide

Journal of Infectious Diseases

Volumn 179, Issue 6, 1999, Pages 1433-1440

  Hutchins, Wendy A ^a,b,c   Carlone, George M ^a,b   Westerink, M A Julie ^a,b  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL ANTIGEN TI2; BACTERIUM LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ELDERLY CARE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; MALE; NEISSERIA MENINGITIDIS; PRIORITY JOURNAL; SEROTYPE; SERUM BACTERICIDAL ACTIVITY; STRAIN DIFFERENCE;

ADULT; AGED; AGED, 80 AND OVER; AGING; ANTIBODIES, BACTERIAL; ANTIGENS, T-INDEPENDENT; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN ISOTYPES; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOGLOBULIN M; MALE; MIDDLE AGED; NEISSERIA MENINGITIDIS; POLYSACCHARIDES, BACTERIAL; VACCINATION;

EID: 0033022731     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/314750     Document Type: Article

References (63)

1. 1. Callahan CM, Wolinsky FD. Hospitalization for pneumonia among older adults. J Gerontol A Biol Sci Med Sci 1996;51:M276-82.
2. 2. Granton JT, Grossman RF. Community-acquired pneumonia in the elderly patient. Clin Chest Med 1993;14:537-53.
3. 3. Miller RA. The aging immune system: primer and prospectus. Science 1996;273:70-4.
4. 4. Ben-Yehuda A, Weksler ME. Host resistance and the immune system. Clin Geriatric Med 1972;8:701-11.
5. 5. Paganelli R, Scala E, Quinti I, Ansotegui IJ. Humoral immunity in aging. Aging (Milano) 1994;6:143-50.
6. 6. Buckley CEI, Buckley EG, Dorsey FC. Longitudinal changes in serum immunoglobulin levels in older humans. Fed Proc 1974;33:2036-9.
7. 7. Schulze DH, Goidl EA. Age-associated changes in antibody-forming cells (B cells). Proc Soc Exp Biol Med 1991;196:253-9.
8. 8. Shapiro ED, Berg AT, Austrian R, et al. The protective efficacy of polyvalent pneumococcal polysaccharide vaccine. N Engl J Med 1991;325:1453-60.
9. 9. Konradsen HB. Quantity and avidity of pneumococcal antibodies before and up to five years after pneumococcal vaccination of elderly persons. Clin Infect Dis 1995;21:616-20.
10. 10. Fattal-German M, Taillandier J, Mathieu D, Bizzini B. Pneumococcal vaccination of elderly individuals. Vaccine 1991;9:542-4.
11. 11. Makinodan T. Patterns of age-related immunologic changes. Nutr Rev 1995;53:S27-34.
12. 12. Jackson LA, Wenger JD. Laboratory-based surveillance for meningococcal disease in selected areas. United States, 1989-1991. Mor Mortal Wkly Rep CDC Surveill Summ 1993;42(SS-2):21-30.
13. 13. Whalen CM, Hockin JC, Ryan A, Ashton F. The changing epidemiology of invasive meningococcal disease in Canada, 1985 through 1992: emergence of a virulent clone of Neisseria meningitidis. JAMA 1995;273:390-4.
14. 14. Ceesay SJ, Allen SJ, Menon A, et al. Decline in meningococcal antibody levels in African children 5 years after vaccination and the lack of an effect of booster immunization. J Infect Dis 1993;167:1212-6.
15. 15. Zangwill KM, Stout RW, Carlone GM, et al. Duration of antibody response after meningococcal polysaccharide vaccination in US Air Force personnel. J Infect Dis 1994;169:847-52.
16. 16. Jackson LA, Schuchat A, Reeves MW, Wenger JD. Serogroup C meningococcal outbreaks in the United States. An emerging threat. JAMA 1995;273:383-9.
17. 17. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE. Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non type-specific cell wall polysaccharide. J Infect Dis 1990;161:728-35.
18. 18. Holder PK, Maslanka SE, Pais LB, Dykes J, Plikaytis BD, Carlone GM. Assignment of Neisseria meningitidis serogroup A and C class specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin Diagn Lab Immunol 1995;2:132-7.
19. 19. Gheesling LL, Carlone GM, Pais LB, et al. Multicenter comparison of Neisseria meningitidis serogroup C anti capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. J Clin Microbiol 1994;32:1475-82.
20. 20. Plikaytis BD, Holder PF, Pais LB, Maslanka SE, Gheesling LL, Carlone GM. Determination of parallelism and nonparallelism in bioassay dilution curves. J Clin Microbiol 1994;32:2441-7.
21. 21. Maslanka SE, Gheesling LL, Libutti DE, et al. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C bactericidal assays. Clin Diagn Lab Immunol 1997;4:156-67.
22. 22. Ambrosino DM, Barrus VA, DeLange GG, Siber GR. Correlation of the Km(1) immunoglobulin allotype with anti-polysaccharide antibodies in caucasian adults. J Clin Invest 1986;78:361-5.
23. 23. Gotschlich EC, Rey M, Triau R, Sparks KS. Quantitative determination of the human immune response to immunization with meningococcal vaccines. J Clin Invest 1972;51:89-96.
24. 24. Park MK, Sun Y, Olander JV, Hoffmann JW, Nahm MH. The repertoire of human antibodies to the carbohydrate capsule of Streptococcus pneumoniae 6B. J Infect Dis 1996;174:75-82.
25. 25. Ruben FL, Uhrin M. Specific immunoglobulin-class antibody responses in the elderly before and after 14-valent pneumococcal vaccine. J Infect Dis 1985;151:845-9.
26. 26. Jelonek MT, Chang SJ, Chiu CY, Park MK, Nahm MH, Ward JI. Comparison of naturally acquired and vaccine-induced antibodies to Haemophilus influenzae type b capsular polysaccharide. Infect Immun 1993; 61:5345-50.
27. 27. Rautonen N, Pelkonen J, Sipinen S, Käyhty H, Mäkelä O. Isotype concentrations of human antibodies to group A meningococcal polysaccharide. J Immunol 1986;137:2670-5.
28. 28. Skevakis L, Frasch CE, Zahradnik JM, Dolin R. Class-specific human bactericidal antibodies to capsular and noncapsular antigens of Neisseria meningitidis. J Infect Dis 1984;149:387-96.
29. 29. Gotschlich EC, Goldschneider I, Artenstein MS. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 1969;129: 1367-84.
30. 30. Beuvery EC, Leussink AB, van Delft RW, Tiesjema RH, Nagel J. Immunoglobulin M and G responses and persistence of these antibodies in adults after vaccination with a combined meningococcal group A and group C polysaccharide vaccine. Infect Immun 1982;37:579-85.
31. 31. Herrmann DJ, Hamilton RG, Barington T, et al. Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology. J Immunol Methods 1992;148:101-14.
32. 32. Barington T, Juul L, Gyhrs A, Heilmann C. Heavy-chain isotype patterns of human antibody-secreting cells induced by Haemophilus influenzae type b conjugate vaccines in relation to age and preimmunity. Infect Immun 1994;62:3066-74.
33. 33. Hazlewood M, Nusrat R, Kumararatne DS, et al. The acquisition of anti-pneumococcal capsular polysaccharide Haemophilus influenzae type b and tetanus toxoid antibodies, with age, in the UK. Clin Exp Immunol 1993;93:157-64.
34. 34. Barrett DJ, Ayoub EM. IgG2 subclass restriction of antibody to pneumococcal polysaccharides. Clin Exp Immunol 1986;63:127-34.
35. 35. Riesen WF, Skvaril F, Braun DG. Natural infection of man with group A streptococci. Scand J Immunol 1976;5:383-90.
36. 36. Shackelford PG, Granoff DM, Nelson SJ, Scott MG, Nahm MH. Subclass distribution of human antibodies to Haemophilus influenzae type b capsular polysaccharide. J Immunol 1987;138:587-92.
37. 37. Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969;129: 1307-26.
38. 38. Aase A, Michaelsen TE. Opsonophagocytic activity induced by chimeric antibodies of the four human IgG subclasses with or without help from complement. Scand J Immunol 1994;39:581-7.
39. 39. Aase A, Bjune G, Hoiby EA, Rosenqvist E, Pedersen AK, Michaelsen TE. Comparison among opsonic activity, antimeningococcal immunoglobulin G response, and serum bactericidal activity against meningococci in sera from vaccinees after immunization with a serogroup B outer membrane vesicle vaccine. Infect Immun 1995;63:3531-6.
40. 40. Schreiber JR, Barrus V, Cates KL, Siber GR. Functional characterization of human IgG, IgM, and IgA antibody directed to the capsule of Haemophilus influenzae type b. J Infect Dis 1986;153:8-16.
41. 41. Amir J, Scott MC, Nahm MH, Granoff DM. Bactericidal and opsonic activity of IgG1 and IgG2 anticapsular antibodies to Haemophilus influenzae type b. J Infect Dis 1990;162:163-71.
42. 42. Jarvis GA, Griffiss JM. Human IgA1 initiates complement-mediated killing of Neisseria meningitidis. J Immunol 1989;143:1703-9.
43. 43. Sankilampi U, Honkanen PO, Bloigu A, Leinonen M. Persistence of antibodies to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1997;176:1100-4.
44. 44. Ammann AJ, Schiffman G, Austrian R. The antibody responses to pneumococcal capsular polysaccharides in aged individuals. Proc Soc Exp Biol Med 1980;164:312-6.
45. 45. Musher DM, Groover JE, Graviss EA, Baughn RE. The lack of association between aging and postvaccination levels of IgG antibody to capsular polysaccharides of Streptococcus pneumoniae. Clin Infect Dis 1996;22: 165-7.
46. 46. Musher DM, Chapman AJ, Gorce A, Jonsson S, Briles D, Banghu RE. Natural and vaccine-related immunity to Streptococcus pneumoniae. J Infect Dis 1986;154:245-56.
47. 47. Romero-Steiner S, Pais LB, Groover J, et al. Evaluation of functional antibody responses in elderly and middle aged vaccinees to the 23-valent pneumococcal polysaccharide vaccine (abstract E-64). In: Proceedings of the 97th annual general meeting of the American Society for Microbiology (Miami, FL), Washington, DC: ASM, 1997:251.
48. 48. Hedlund JU, Kalin ME, Örtqvist AB, Hebrichsen J. Antibody response to pneumococcal vaccine in middle-aged and elderly patients recently treated for pneumonia. Arch Intern Med 1994;154:1961-5.
49. 49. Butler JC, Breiman RF, Campbell JF, Lipman HB, Broome CV, Facklam RR. Pneumococcal polysaccharide vaccine efficacy. An evaluation of current recommendations. JAMA 1993;270:1826-31.
50. 50. Nuorti PJ, Butler JC, Breiman RF. Prevention of pneumococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1997;46(RR-8):1-24.
51. 51. Nicoletti C. Antibody protection in aging: influence of idiotypic repertoire and antibody binding activity to a bacterial antigen. Exp Mol Pathol 1995;62:99-108.
52. 52. Nicoletti C, Cerny J. The repertoire diversity and magnitude of antibody responses to bacterial antigens in aged mice: I. Age-associated changes in antibody responses differ according to the mouse strain. Cell Immunol 1991;133:72-83.
53. L gene repertoire and in specificity. J Immunol 1991;147:2750-5.
54. 54. Nicoletti C, Yang X, Cerny J. Repertoire diversity of antibody response to bacterial antigens in aged mice. III. Phosphorylcholine antibody from young and aged mice differ in structure and protective activity against infection with Streptococcus pneumoniae. J Immunol 1993; 150:543-9.
55. 55. Lucas A, Reason D. Aging and the immune response to the Haemophilus influenzae type b capsular polysaccharide: Retention of the dominant idiotype and antibody function in the elderly. Infect Immun 1998;66:1752-4.
56. 56. Percival RS, Marsh PD, Challacombe SJ. Serum antibodies to commensal oral and gut bacteria vary with age. FEMS Immunol Med Microbiol 1996;15:35-42.
57. 57. Miller RA. Immune system. In: Masoro EJ, ed. Handbook of physiology: aging. American Physiological Society, Bethesda, MD, Baltimore: Williams & Wilkins, 1995:555-90.
58. 58. Gon Y, Hashimoto S, Hayashi S, Koura T, Matsumoto K, Horie T. Lower serum concentrations of cytokines in elderly patients with pneumonia and the impaired production of cytokines by peripheral blood monocytes in the elderly. Clin Exp Immunol 1996;106:120-6.
59. 59. Albright JW, Albright JF. Age-associated impairment of murine natural killer activity. Proc Natl Acad Sci USA 1983;80:6371-5.
60. 60. Weindruch R, Devens BH, Raff HV, Walford RL. Influence of dietary restriction and aging on natural killer cell activity. J Immunol 1983;130: 993-6.
61. 61. Ambrosino DM, Wang M, Ciamarra A, et al. T cells and natural killer cells regulate human IgG subclass concentrations in SCID mice. Cell Immunol 1994;155:134-43.
62. 62. Larnan JD, Claassen E. T-cell independent and T-cell dependent humoral immunity. In: Snapper CM, ed. Cytokine regulation of humoral immunity: basic and clinical aspects. New York, NY: John Wiley & Sons, 1996:23-72.
63. 63. Sankilampi U, Honkanen PO, Bloigu A, Herva E, Leinonen M. Antibody response to pneumococcal capsular polysaccharide vaccine in the elderly. J Infect Dis 1996;173:387-93.